All In MedTech

Device Trial Radar · NCT02447120

Topcon 3D OCT-1 Maestro Reference Database Study II

Last checked: Nov 19, 2026Latest source record: Jun 8, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

504

Actual

Start

May 2015

Primary completion

Oct 2015

Study completion Oct 2015

Sponsor

Lead sponsor
Topcon Medical Systems, Inc.Not on our public-company list
Sponsor type
Industry
First posted
May 18, 2015

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The objective of this study is to collect OCT measurement data on normal healthy eyes in order to determine the reference limits for Topcon 3D OCT-1 Maestro based on the percentile points for 1%, 5%, 95%, and 99%.

Conditions

  • Healthy

Interventions

  • 3D OCT-1 MaestroDevice

    OCT machines used for diagnostic purposes

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Retinal ThicknessTime frame: 1 minute

Locations

7 sites in 1 country. Site status is shown where the registry gives one.

  • UAB School of Optometry

    Birmingham, Alabama

  • Southern California College of Optometry

    Fullerton, California

  • Valley Eyecare Center

    Livermore, California

4 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.